Astal Laboratories Board Meeting on Aug 14 to Approve Q1 FY27 Results

Astal Laboratories Ltd has announced a Board of Directors meeting scheduled for August 14, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the auditors' limited review report. Additionally, the meeting will address any other business with the chair's permission. In compliance with SEBI regulations, the trading window for designated persons and their relatives will be closed from July 1, 2026, until 48 hours after the board meeting concludes.